Screener
Zevra Therapeutics, Inc. ZVRA Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s long-term debt?
- Zevra Therapeutics, Inc. (ZVRA) reported long-term debt of $0 in Q2 2026.
- How has Zevra Therapeutics, Inc.'s long-term debt changed year-over-year?
- Zevra Therapeutics, Inc.'s long-term debt decreased by 100.0% year-over-year, from $60.69M to $0.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Zevra Therapeutics, Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude